Cargando…
Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
CD133 has been identified as a putative cancer stem cell (CSC) marker in various cancers including colorectal cancer. The relation between CD133 expression and biological characteristics of colorectal cancer remains to be clarified. Protein expression of CD133 was immunohistochemically evaluated in...
Autores principales: | Hongo, Kumiko, Kazama, Shinsuke, Sunami, Eiji, Tsuno, Nelson H., Takahashi, Koki, Nagawa, Hirokazu, Kitayama, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466429/ https://www.ncbi.nlm.nih.gov/pubmed/22246526 http://dx.doi.org/10.1007/s12032-012-0161-8 |
Ejemplares similares
-
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study
por: Hongo, Kumiko, et al.
Publicado: (2015) -
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
por: Kitayama, Joji, et al.
Publicado: (2010) -
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
por: Yasuda, Koji, et al.
Publicado: (2011) -
Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer
por: Kitayama, Joji, et al.
Publicado: (2011) -
Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets
por: Tada, Noriko, et al.
Publicado: (2015)